ARCpoint Inc
ARC
Minas Metals Ltd
MINA
Quri-Mayu Developments Ltd
QURI
KGL Resources Ltd
KGL.H
Alerio Gold Corp
ALE
CA Stock MarketDetailed Quotes
APLI Appili Therapeutics Inc
- 0.040
- 0.0000.00%
15min DelayMarket Closed Dec 13 16:00 ET
4.85MMarket Cap-1.33P/E (TTM)
0.040High0.035Low13.61KVolume0.035Open0.040Pre Close481.00Turnover0.06052wk High0.01%Turnover Ratio121.27MShares0.02552wk Low-0.03EPS TTM4.27MFloat Cap1.890Historical HighLossP/E (Static)106.83MShs Float0.025Historical Low-0.03EPS LYR12.50%Amplitude--Dividend TTM-0.37P/B1Lot Size--Div YieldTTM
Appili Therapeutics Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 272.48%409.03K | 93.47%-132.08K | 75.59%-2.46M | 58.83%-456.69K | 126.45%253.24K | 92.34%-237.14K | 59.01%-2.02M | 47.08%-10.1M | 71.29%-1.11M | 83.71%-957.3K |
| Net income from continuing operations | 23.87%-743.49K | -2.35%-1.58M | 59.09%-3.78M | 58.53%-1.1M | 94.18%-152.34K | 40.39%-976.56K | 33.39%-1.55M | 63.20%-9.24M | 20.18%-2.66M | 19.13%-2.62M |
| Operating gains losses | -199.90%-95.9K | 136.82%52.61K | -108.81%-35.54K | 153.88%113.87K | -103.77%-102.51K | -61.69%95.99K | -190.32%-142.89K | 801.86%403.29K | 140.86%44.85K | -221.39%-50.31K |
| Depreciation and amortization | -18.30%2.81K | -2.24%3.37K | 118.03%13.66K | 108.44%3.39K | 119.33%3.39K | 122.64%3.44K | 122.21%3.44K | -50.44%6.27K | -52.29%1.62K | -46.95%1.55K |
| Remuneration paid in stock | -12.19%14.27K | -45.70%80.01K | -78.13%191.35K | -97.31%10.05K | -91.08%17.7K | -90.49%16.25K | 11.39%147.35K | -57.10%875.12K | -1.76%373.49K | -69.91%198.53K |
| Other non cashItems | 468.65%509.25K | 222.72%1.23M | -55.70%485.58K | -90.02%84.17K | 29.27%158.07K | -226.20%-138.14K | 120.36%381.47K | -29.51%1.1M | -26.76%843.04K | -49.67%122.28K |
| Change In working capital | -5.22%722.09K | 109.92%85.74K | 120.44%661.44K | 50.94%435.31K | -76.34%328.92K | 141.49%761.87K | 71.91%-864.66K | -230.10%-3.24M | 114.75%288.41K | 138.78%1.39M |
| -Change in receivables | 4,454.55%1.04M | 31.87%-615K | -177.56%-752.55K | -116.11%-71.67K | -17.39%199.01K | 680.77%22.78K | -420.47%-902.67K | 228.83%970.29K | 41.28%444.8K | 221.02%240.91K |
| -Change in prepaid assets | -93.47%4.01K | 238.54%75.73K | 181.31%38.67K | -26.76%37.41K | -107.00%-5.46K | -36.58%61.39K | 80.01%-54.67K | -117.78%-47.55K | -5.84%51.07K | -16.32%78.07K |
| -Change in payables and accrued expense | -147.16%-319.58K | 574.42%625.01K | 133.07%1.38M | 326.34%469.57K | -87.36%135.38K | 135.00%677.7K | 103.00%92.67K | -316.08%-4.16M | 91.07%-207.46K | 148.39%1.07M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 272.48%409.03K | 93.47%-132.08K | 75.59%-2.46M | 58.83%-456.69K | 126.45%253.24K | 92.34%-237.14K | 59.01%-2.02M | 47.08%-10.1M | 71.29%-1.11M | 83.71%-957.3K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1.66K | 0 | -815.37%-29.06K | 109.80%654 | 0 | 0 | -897.77%-29.72K | -100.06%-3.18K | -923.06%-6.68K | 0 |
| Net PPE purchase and sale | ---1.66K | --0 | -815.37%-29.06K | 109.80%654 | --0 | --0 | -897.77%-29.72K | ---3.18K | -923.06%-6.68K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---1.66K | --0 | -815.37%-29.06K | 109.80%654 | --0 | --0 | -897.77%-29.72K | -100.06%-3.18K | -923.06%-6.68K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -138.46%-42.97K | 214.59%338.43K | -97.93%122.05K | -102.38%-51.37K | -8.63%-45.88K | 364.29%111.72K | -97.20%107.58K | -38.23%5.91M | 103.32%2.16M | -100.80%-42.24K |
| Net issuance payments of debt | -120.46%-26.65K | 181.79%357.24K | -91.57%203.58K | -101.02%-25.32K | -29.49%-28.1K | 717.22%130.22K | 718.41%126.78K | -36.95%2.41M | 78.87%2.48M | 97.87%-21.7K |
| Net common stock issuance | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -39.86%3.21M | --0 | --0 |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -24.36%1.29M | --0 | --0 |
| Interest paid (cash flow from financing activities) | 11.74%-16.33K | 2.01%-18.81K | 13.02%-72.52K | 14.27%-17.04K | 13.41%-17.78K | 12.63%-18.5K | 11.89%-19.2K | 10.35%-83.38K | 11.24%-19.88K | 10.62%-20.54K |
| Net other financing activities | ---- | ---- | 99.02%-9.01K | ---- | ---- | ---- | ---- | 24.10%-922.61K | 0.38%-300.65K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -138.46%-42.97K | 214.59%338.43K | -97.93%122.05K | -102.38%-51.37K | -8.63%-45.88K | 364.29%111.72K | -97.20%107.58K | -38.23%5.91M | 103.32%2.16M | -100.80%-42.24K |
| Net cash flow | ||||||||||
| Beginning cash position | -42.13%301.27K | -96.17%94.49K | -63.00%2.47M | -57.76%602.88K | -83.69%395.62K | -90.63%520.59K | -63.00%2.47M | -39.76%6.66M | -84.77%1.43M | -75.71%2.43M |
| Current changes in cash | 390.55%364.4K | 110.60%206.35K | 43.44%-2.37M | -148.73%-507.4K | 120.75%207.36K | 96.00%-125.42K | -77.26%-1.95M | 5.89%-4.19M | 137.17%1.04M | -70.00%-999.54K |
| Effect of exchange rate changes | -198.66%-442 | -39.13%420 | 100.85%54 | 60.98%-988 | -106.68%-96 | -94.53%448 | 105.12%690 | -111.23%-6.38K | -102.69%-2.53K | 105.90%1.44K |
| End cash Position | 68.15%665.22K | -42.13%301.27K | -96.17%94.49K | -96.17%94.49K | -57.76%602.88K | -83.69%395.62K | -90.63%520.59K | -63.00%2.47M | -63.00%2.47M | -84.77%1.43M |
| Free cash from | 271.78%407.37K | 93.57%-132.08K | 75.31%-2.49M | 58.95%-456.69K | 126.45%253.24K | 92.34%-237.14K | 58.41%-2.05M | 47.06%-10.1M | 71.20%-1.11M | 83.71%-957.3K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.